What is the success rate of TMS? For treatment-resistant depression, commonly cited estimates suggest that about 50-60% of patients respond to treatment and roughly 30-40% achieve remission. These figures vary by study, treatment protocol, and patient group, so they cannot predict an individual patient’s outcome.
Understanding the difference between response and remission can help you evaluate treatment claims and discuss realistic goals with a psychiatric provider. Research findings, clinical assessment, and follow-up care all play a role in determining whether TMS may be an appropriate option.
Key Takeaways
- TMS response rates for treatment-resistant depression are commonly estimated at 50-60%, while remission rates are roughly 30-40%. Actual results vary by study and treatment protocol.
- Response means depressive symptoms have decreased substantially, while remission means symptoms have fallen below a defined clinical threshold.
- Treatment history, the TMS protocol, and follow-up care can affect outcomes. A psychiatric evaluation can help determine whether TMS is appropriate and how progress should be measured.
What Is the TMS Therapy Success Rate?
The reported success rate varies because researchers and clinics do not always define success in the same way. For treatment-resistant depression, a response rate of about 50–60% and a remission rate of 30-40% are commonly cited estimates, but individual studies may report different results.
Response generally means that depressive symptoms have decreased substantially, often by at least 50% on a standardized rating scale. Remission means that symptoms have decreased to a level below a defined clinical threshold. A person may respond to treatment without reaching remission, and remission does not guarantee that depression will never return.
According to a 2023 meta-analysis of randomized, sham-controlled trials published on PubMed,
“Repetitive transcranial magnetic stimulation (rTMS), when used alongside standard care, improved response and remission outcomes in patients with major depressive disorder who had not responded adequately to at least two antidepressant treatments.” – PubMed
The analysis included 19 studies assessing response and nine assessing remission, although the authors reported smaller treatment effects than some earlier research had suggested.
Study design matters when interpreting these results. A controlled clinical trial compares active treatment with a sham procedure, while a real-world clinic report may include patients receiving medication or psychotherapy at the same time. These studies provide useful but different types of evidence.
The following terms help explain how researchers measure treatment outcomes.
| Measure | What it means | How to interpret it |
| Response | A substantial reduction in depressive symptoms, often at least 50% on a rating scale | Symptoms have improved but may remain |
| Remission | Symptoms fall below a defined clinical threshold | Symptoms are minimal according to the measure used, but relapse remains possible |
| Partial response | Symptoms improve but do not meet the study’s response threshold | Further assessment or treatment may be appropriate |
| Nonresponse | Symptoms do not improve enough to meet the study’s response definition | The clinician may review the treatment plan and discuss alternatives |
| Sustained response | Improvement continues during a specified follow-up period | The result depends on when and how researchers measure symptoms |
A success-rate estimate is most meaningful when it identifies the patient group, treatment protocol, outcome definition, and follow-up period. For people exploring depression treatment options, understanding these measures can help them discuss the potential benefits and limitations of TMS with a clinician.
What Counts as a Successful TMS Outcome?

A successful outcome may involve fewer depressive symptoms, remission, or meaningful improvements in daily functioning. The most relevant measure depends on the patient’s treatment goals and the clinical criteria used to assess progress.
Researchers often use standardized depression rating scales to compare symptoms before and after treatment. However, a change in a rating score does not capture every aspect of recovery. Someone may find it easier to concentrate, return to work, or participate in social activities while still experiencing some depressive symptoms.
Clinical assessment can consider several areas of daily life:
- Mood: Whether low mood or feelings of hopelessness become less frequent or severe.
- Interest and motivation: Whether activities that previously felt difficult become easier to start or enjoy.
- Sleep and energy: Whether sleep patterns and daytime energy improve.
- Concentration: Whether the person can focus more effectively on tasks and decisions.
- Daily functioning: Whether work, relationships, and routine responsibilities become more manageable.
Best Life Psychiatry reports that 83% of patients who complete a full NeuroStar TMS course experience measurable improvement and approximately 62% achieve remission.
These are practice-reported figures associated with NeuroStar outcomes, rather than universal rates for every TMS device or treatment program. Because the figures describe patients who complete treatment, they should not be directly compared with studies that include everyone who starts treatment.
The practice’s NeuroStar TMS therapy information describes its treatment approach. When reviewing a clinic’s reported outcomes, ask how many patients were included, how success was defined, whether the data included treatment dropouts, and when symptoms were measured.
A responsible treatment plan should also explain what happens if symptoms improve only partly or do not improve enough.
Why Do TMS Success Rates Vary?

TMS success rates vary because studies differ in patient populations, treatment protocols, and outcome measurements. Several factors can influence reported results:
- Previous treatment history: Outcomes may differ depending on how many treatments a person has tried and whether they helped.
- Diagnosis: Most success-rate estimates discussed here concern major depressive disorder. Other conditions require condition-specific evidence.
- TMS protocol: Standard rTMS, deep TMS, and theta-burst stimulation use different treatment approaches, so their results are not directly interchangeable.
- Treatment completion: Studies that report only outcomes among people who complete treatment may show higher rates than studies that include everyone who starts.
- Outcome measurement and follow-up: Response means symptoms have decreased substantially, while remission means symptoms have improved to a minimal level. Results measured immediately after treatment may not reflect long-term outcomes.
As reported in a large observational registry of routine clinical practice published in the Journal of Affective Disorders,
real-world treatment with the NeuroStar TMS System showed significant antidepressant efficacy for major depressive disorder. Across patient self-reports and clinician ratings, response rates reached between 58% and 83%, while remission rates were observed between 28% and 62% – Sackeim et al., 2020.
A clinician can assess previous treatment response, current symptoms, medical history, and potential safety concerns to determine whether TMS is appropriate. Comparing studies with similar patients, protocols, and outcome measures provides a more reliable understanding of expected results.
How Should You Compare Clinic Claims With Research?

You can evaluate clinic claims more accurately by checking how each success rate was calculated and whether the supporting evidence applies to the treatment being offered. A headline percentage alone rarely provides enough information to assess likely outcomes.
Before choosing a provider, ask the following questions:
- Does the percentage describe response, remission, or another outcome?
- Does it include everyone who started treatment or only those who completed it?
- How many patients were included in the analysis?
- Was improvement measured immediately after treatment or during later follow-up?
- Which TMS device and treatment protocol were used?
- Were patients also receiving medication or psychotherapy?
- Is the claim based on a published study, a clinical trial, or a practice’s own patient data?
When comparing providers, patients can review the clinic’s location, available treatment services, and evaluation process. For local information, see TMS therapy in Hot Springs, Arkansas.
Is TMS Therapy Right for You?
If depression hasn’t improved enough with medication, it can be frustrating to keep searching for a treatment that fits your needs. When asking what is the success rate of TMS?, remember that personal treatment history and clinical evaluations matter most. There’s no guaranteed outcome.
Best Life Psychiatry in Benton, Arkansas, offers NeuroStar TMS alongside medication management and Spravato, giving eligible patients options to discuss with a board-certified psychiatric team.
If you’re considering TMS, contact Best Life Psychiatry to discuss clinical eligibility, insurance verification, and scheduling an evaluation.
FAQs
What Is the Success Rate of TMS?
For treatment-resistant depression, commonly cited estimates indicate that approximately 50-60% of patients respond to TMS and 30–40% achieve remission. These rates vary by study, treatment protocol, and patient population, so they cannot predict an individual patient’s outcome.
How Many TMS Sessions Are Usually Needed?
A standard NeuroStar TMS course at Best Life Psychiatry typically includes approximately 36 sessions over six to seven weeks. The clinician will recommend a schedule based on the treatment protocol, the patient’s clinical needs, and their response to treatment.
How Soon Can Someone Notice Improvement From TMS?
Some patients notice improvements in depressive symptoms within the first few weeks of treatment, while others require more time to respond. The treating clinician evaluates changes in mood, sleep, energy, and daily functioning throughout the treatment course to assess progress.
Can TMS Help When Antidepressants Have Not Worked?
TMS may help adults with major depressive disorder who have not experienced sufficient improvement with antidepressant medication. A psychiatric evaluation can determine whether TMS is appropriate based on the patient’s treatment history, current symptoms, medical history, and other clinical considerations.
Does a High TMS Response Rate Mean the Treatment Will Work for Everyone?
No, a high response rate does not guarantee that every patient will benefit from TMS. Before starting treatment, ask the provider how the practice defines success, which patients are included in its outcome data, and how the clinical team will assess progress if symptoms persist.



